Table 7.

Pathological stage in the untreated and treated patients with clinical stage C disease

Pathological stage	Surgery only (%)	12 weeks of NHT (%)	24 weeks of NHT (%)
B	3 (10.4%)	11 (31.4%)	19 (61.2%)
C1	11 (37.9%)	13 (37.1%)	3 (9.7%)
C2	5 (17.2%)	5 (14.3%)	6 (19.4%)
D1	10 (34.5%)	6 (17.2%)	3 (9.7%)
Total	29	35	31

Chi square=22.152; p=0.001. Untreated versus 12 weeks of NHT: χ²=5.221; p=0.207 (not significant (NS)). Untreated versus 24 weeks of NHT: χ²=20.024; p<0.001. 12 weeks of NHT versus 24 weeks of NHT: χ²=9.266; p=0.033 (NS).

NHT, neoadjuvant hormonal treatment.